Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Blood|April 30, 2005
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis CDavid Butera, Svetlana Marukian, Amy E Iwamaye, et al.
Journal of Viral Hepatitis|October 3, 2025
Identifying Varying Influences on Eliminating Hepatitis C Across Medical SpecialtiesChristopher J Gonzalez, Clarence N Perez-Mejia, Noelia Hernandez, et al.
Journal of Hepatology|October 27, 2010
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patientsMarie-Louise C Vachon, Stephanie H Factor, Andrea D Branch, et al.
Hepatology (Baltimore, Md.)|May 10, 2014
Telaprevir-based treatment effects on hepatitis C virus in liver and bloodAndrew H Talal, Rositsa B Dimova, Eileen Z Zhang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 31, 2011
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirinAndrew H Talal, Ruei-Chi Liu, Marija Zeremski, et al.
The Journal of Infectious Diseases|December 12, 2017
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin DosageAndrew H Talal, Emily O Dumas, Barbara Bauer, et al.
The Journal of Infectious Diseases|March 24, 2020
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S SubstudyAshwin Balagopal, Laura M Smeaton, Jeffrey Quinn, et al.
Journal of Substance Abuse Treatment|June 17, 2021
Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managersAndrew H Talal, Urmo Jaanimägi, Kathleen Davis, et al.
Journal of Public Health Management and Practice : JPHMP|August 18, 2023
Hepatitis C Virus Elimination Programs in Louisiana and Washington: Importance of Screening and Surveillance SystemsAndrew H Talal, Arpan Dharia, Shashi N Kapadia, et al.
Clinical Pharmacology and Therapeutics|December 24, 2019
Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus InfectionWei Gao, Andrea L Webber, Jill Maxwell, et al.
Pageof 11